| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $372M | — | $362M | — | 2.7% |
| Op. Income | $102M | — | $98M | — | 3.9% |
| Gross Margin | 64.0% | — | 61.9% | — | 2.1pp |
| Net Margin | 23.9% | — | 22.0% | — | 1.9pp |
| EPS (Diluted) | $5.46 | — | $4.93 | — | 10.8% |
| Free Cash Flow | $11M | — | $93M | — | -87.9% |
| Item | Amount |
|---|---|
| REVENUE | $372M |
| Cost of Revenue | $134M |
| GROSS PROFIT | $238M |
| R&D Expenses | $0 |
| Selling & Marketing | $95M |
| General & Administrative | $15M |
| SG&A Expenses | $110M |
| Other Expenses | $26M |
| Operating Expenses | $136M |
| Cost & Expenses | $270M |
| OPERATING INCOME | $102M |
| Interest Income | $330M |
| Interest Expense | $129M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $102M |
| Income Tax Expense | $13M |
| Net Income from Continuing Ops | $89M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $89M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $89M |
| D&A | $4M |
| EBIT | $102M |
| EBITDA | $107M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| REVENUE | $372M |
| Cost of Revenue | $134M |
| GROSS PROFIT | $238M |
| R&D Expenses | $0 |
| Selling & Marketing | $95M |
| General & Administrative | $15M |
| SG&A Expenses | $110M |
| Other Expenses | $26M |
| Operating Expenses | $136M |
| Cost & Expenses | $270M |
| OPERATING INCOME | $102M |
| Interest Income | $330M |
| Interest Expense | $129M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $102M |
| Income Tax Expense | $13M |
| Net Income from Continuing Ops | $89M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $89M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $89M |
| D&A | $4M |
| EBIT | $102M |
| EBITDA | $107M |
| EPS | $5 |
| EPS Diluted | $5 |
| Item | Amount |
|---|---|
| Net Income | $89M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $10M |
| Change in Working Capital | -$81M |
| OPERATING CASH FLOW | $18M |
| Capital Expenditure | -$7M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$106M |
| NET CASH FROM INVESTING | -$106M |
| Net Debt Issuance | -$31M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$24M |
| Other Financing Activities | $222M |
| NET CASH FROM FINANCING | $168M |
| FREE CASH FLOW | $11M |
| Net Change in Cash | $80M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $473M |
| Short-Term Investments | $1.1B |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1.6B |
| PP&E (Net) | $62M |
| Goodwill | $73M |
| Intangible Assets | $20M |
| Long-Term Investments | $4.8B |
| Tax Assets | $0 |
| Other Non-Current Assets | $340M |
| TOTAL NON-CURRENT ASSETS | $5.3B |
| TOTAL ASSETS | $6.8B |
| Account Payables | $0 |
| Short-Term Debt | $232M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $5.3B |
| TOTAL CURRENT LIABILITIES | $5.5B |
| Long-Term Debt | $594M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $594M |
| TOTAL LIABILITIES | $6.1B |
| Common Stock | $349M |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $399M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$24M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $725M |
| Minority Interest | $0 |
| TOTAL EQUITY | $725M |
| TOTAL LIABILITIES & EQUITY | $6.8B |
| Total Debt | $826M |
| Net Debt | $353M |